COX-2 is a novel target in therapy of mycosis fungoides

K. L.M. Kopp, S. Dabelsteen, T. Krejsgaard, K. W. Eriksen, C. Geisler, J. C. Becker, M. Wasik, N. Odum, A. Woetmann

Research output: Contribution to journalLetterpeer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'COX-2 is a novel target in therapy of mycosis fungoides'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science